Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hepatic Impairment × tazemetostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma, Follicular 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Prostatic Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Hepatic Impairment 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04241835 2026-04-16

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Ipsen

Phase 1 Terminated

Other solid neoplasm

Hepatic Impairment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡